GLP-1 and Muscle Loss: What the Science Actually Says

You started a GLP-1 medication, the scale is finally moving, and then you read a headline warning that you might be losing muscle along with the fat. It's a fair worry, and it deserves a straight answer rather than a scare. Yes, some of the weight people lose on these medications is lean mass, not just fat. But losing lean mass on the scale is not the same as getting weaker, and there is a lot you can do to protect your strength while you lose weight.

Here is what the research actually shows about GLP-1 medications and muscle loss, who is most at risk, and the simple, evidence-backed habits that help you keep the muscle that matters.

Do GLP-1 medications cause muscle loss?

Short answer: any rapid weight loss, whether from a GLP-1 medication, surgery, or aggressive dieting, comes partly from lean (non-fat) tissue. GLP-1 receptor agonists like semaglutide are not unique in this. When you lose weight, your body sheds both fat and some lean mass, which includes muscle, water, and other tissue.

The most-cited data come from the STEP 1 trial of once-weekly semaglutide. In its body-composition substudy, roughly 40% of the total weight lost was lean mass and about 60% was fat, with total lean body mass falling 9.7% over 68 weeks (an absolute loss of about 6.9 kg of lean tissue versus 10.4 kg of fat). Across other recent GLP-1 and dual GLP-1/GIP trials, lean soft tissue made up roughly 25% to 40% of total weight lost.

One reassuring nuance from STEP 1: because fat fell faster than lean mass, lean mass as a proportion of total body weight actually went up. People ended up leaner overall, not just lighter.

Does losing lean mass mean you'll get weaker?

Not necessarily, and this is the part that often gets lost in alarming headlines. Lean mass on a scan is not the same thing as functional strength, and several studies suggest strength can hold steady or even improve.

In the SEMALEAN study of people on semaglutide, lean mass dropped early (about 3 kg by month 7) and then stabilized, while handgrip strength, a common real-world measure of muscle function, actually improved by 4.5 kg at month 12. Fat mass meanwhile fell 14% at month 7 and 18% at month 12. A separate systematic review in patients with metabolic-associated fatty liver disease found GLP-1 therapy was not associated with meaningful loss of muscle strength, with early hints of improved muscle quality.

In other words, the number on a body-composition scan can drop while the muscle that lets you climb stairs, carry groceries, and stay independent stays strong.

Who is most at risk?

Muscle preservation matters more for some people than others. The biggest concern is for those who start out with less muscle to spare, where losing lean mass could tip them into a condition called sarcopenia, the medical term for low muscle mass and strength.

Researchers warn that GLP-1-associated lean-mass loss may precipitate or worsen sarcopenic obesity, especially in older or frail individuals with limited muscular reserve.

• Older adults, who naturally lose muscle with age
• Frail or physically inactive people
• Anyone who already has low muscle mass before starting treatment
• People who lose weight very rapidly without strength training or enough protein

How to protect your muscle on GLP-1 medications

This is the good news: muscle loss on GLP-1 medications is not inevitable, and the strategies that help are straightforward. The two biggest levers are protein and resistance training, and the research is clear that combining them beats diet or exercise alone.

Experts recommend a protein intake greater than 1.2 g/kg/day (up to roughly 2 g/kg/day), spread evenly across your meals rather than loaded into one. Pair that with resistance training, lifting weights or doing bodyweight work, about 3 to 5 days per week. Because GLP-1 medications reduce appetite, hitting your protein target can take real intention; many people find it easiest to anchor a protein source at every meal.

• Aim for protein above 1.2 g/kg/day, evenly distributed across meals
• Do resistance training 3-5 days per week
• Stay generally active most days of the week
• Lose weight at a steady pace rather than crash-dieting
• Ask your clinician about checking on muscle and strength as you go

What's next: medications designed to preserve muscle

The field is moving fast on this exact question. Drugmakers and researchers are now testing add-on therapies designed to improve the quality of GLP-1 weight loss by sparing lean mass.

The American Diabetes Association has highlighted trials such as COURAGE, which paired the muscle-targeting drug bimagrumab with semaglutide. Interim COURAGE data suggested about 35% of semaglutide-induced weight loss was lean mass before the adjunct was added, the kind of figure these newer combinations aim to shrink. These approaches are still emerging, so for now, protein and strength training remain the proven foundation.

When to talk to a doctor

You don't need to panic about muscle loss, but you should loop in a clinician if you notice warning signs or fall into a higher-risk group. Reach out if you feel newly weak, are struggling with everyday tasks like standing from a chair or carrying bags, are losing weight very quickly, or are older or already frail.

A clinician can help you set a safe pace of weight loss, dial in your protein and exercise plan, and decide whether your muscle and strength should be monitored. GLP-1 therapy works best as part of a supervised plan, not a solo experiment, and getting personalized guidance is the simplest way to lose fat while keeping the strength you need for the long run.